Background: Chronic arsenicosis is a serious health problem in Bangladesh now due to the intake of arsenic-contaminated groundwater above the safe level of 0.05 mg/L by shallow tube well, throughout the country. About 25 million people in Bangladesh are at risk of chronic arsenic toxicity. Arsenic toxicity is also an alarming situation in many countries of the world. Hence, the study on the health hazard of arsenic contamination, its prevalence, presentation, complication, and management is an important one. Aim: The purpose of this study is to evaluate different cutaneous and mucous membrane manifestations of chronic arsenicosis. Method: The study descriptive was conducted in the Department of Dermatology and Venereology in Chittagong Medical College Hospital. A total of 105 patients of clinically diagnosed chronic arsenicosis were selected for the study. Clinical manifestations of chronic arsenicosis patients were analyzed for different mucocutaneous findings. Result: Evaluation and analysis of findings showed chronic arsenicosis patients had characteristic features of melanosis or leukomelanosis (raindrop pigmentation) in 100% of patients. Another characteristic finding of palmoplantar punctate hyperkeratosis was found in 69.5% of patients of chronic arsenicosis. Other mucocutaneous findings of chronic arsenicosis were cutaneous malignancy such as basal cell carcinoma, squamous cell carcinoma, and Bowen’s disease. Other cutaneous and systemic diseases were also observed in patients of chronic arsenicosis. Conclusion: Characteristic mucocutaneous findings of chronic arsenicosis were melanosis, leukomelanosis (raindrop pigmentation), palmoplantar punctate hyperkeratosis, and cutaneous malignancy. As chronic arsenicosis is a serious health problem in our country, it demands more research on chronic arsenicosis. Further reading click here
Creatine kinase as a biomarker in muscle and heart health
1. **Creatine kinase (CK)** is an enzyme found in high concentrations in tissues with high energy demands—especially **skeletal muscle, heart muscle, and brain**—where it helps regenerate ATP from Creatine phosphate. 2. Because CK leaks into the blood when muscle cell membranes are damaged, its serum level serves as a general **marker of tissue injury** rather than damage to one specific organ. 3. CK exists as different **isoenzymes**—CK-MM (skeletal muscle), CK-MB (heart), and CK-BB (brain)—which help pinpoint the source of the damage. 4. **CK-MB** was long considered the classic biomarker for acute myocardial infarction, rising about 4–6 hours after injury, peaking near 24 hours, and returning to normal within 48–72 hours. 5. Its relatively **short half-life** makes CK-MB particularly valuable for detecting **re-infarction**, because levels fall quickly enough that a new rise is easy to recognize. 6. In skeletal muscle health, total CK is elevated in conditions such a...

0 Comments